We use strictly necessary cookies to make our site work. We would also like to set optional cookies (analytical, functional and YouTube) to enhance and improve our service. You can opt-out of these cookies. By clicking “Accept All Cookies” you can agree to the use of all cookies.

Cookies Statement and Privacy Statement

We use strictly necessary cookies to make our site work. We would also like to set optional cookies (analytical, functional and YouTube) to enhance and improve our service. You can opt-out of these cookies. By clicking “Accept All Cookies” you can agree to the use of all cookies.

Cookies Statement and Privacy Statement

Vaxzevria® (AstraZeneca)

The European Medicines Agency authorised the use of the Vaxzevria® (AstraZeneca) in January 2021. 

This page contains information to support vaccinators who are administering the Vaxzevria® (AstraZeneca).

Materials for Vaccinators

Information from the European Medicines Agency

Information from the World Health Organization

Go to the COVID-19 Page for Health Professionals

This page was updated on 13 April 2021